Micro-entity Accounts - MOLECULOMICS LIMITED

MOLECULOMICS LIMITED - Company Information

08340228 MOLECULOMICS LIMITED 2017-07-31 false 2016-08-01 2017-07-31 true 08340228 2016-08-01 2017-07-31 08340228 2017-07-31 08340228 2016-07-31 08340228 uk-gaap-cd-bus:Director1 2016-08-01 2017-07-31 08340228 uk-gaap-cd-bus:Director2 2016-08-01 2017-07-31 08340228 uk-gaap-cd-bus:AllEntityOfficers 2016-08-01 2017-07-31 uk-gaap-cd-bus:OrdinaryShareClass1 2016-08-01 2017-07-31 uk-gaap-cd-bus:OrdinaryShareClass1 2017-07-31 uk-gaap-cd-bus:OrdinaryShareClass1 2016-07-31 iso4217:GBP shares

Registered Number 08340228

MOLECULOMICS LIMITED

Micro-entity Accounts

31 July 2017

MOLECULOMICS LIMITED Registered Number 08340228

Micro-entity Balance Sheet as at 31 July 2017

	Notes	2017	2016
		£	£
Current assets
Debtors		14,500	17,000
Cash at bank and in hand		59,373	136,847
		73,873	153,847
Creditors: amounts falling due within one year		(19,382)	(11,800)
Net current assets (liabilities)		54,491	142,047
Total assets less current liabilities		54,491	142,047
Total net assets (liabilities)		54,491	142,047
Capital and reserves
Called up share capital	1	1	1
Profit and loss account		54,490	142,046
Shareholders' funds		54,491	142,047

For the year ending 31 July 2017 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 20 September 2017

And signed on their behalf by:
Jonathan G L Mullins, Director

MOLECULOMICS LIMITED Registered Number 08340228

Notes to the Micro-entity Accounts for the period ended 31 July 2017

1Called Up Share Capital
Allotted, called up and fully paid:

	2017 £	2016 £
1 Ordinary shares of £1 each	1	1